Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization

Journal of Pathology

Volumn 200, Issue 3, 2003, Pages 320-326

  Weiss, Marjan M ^a   Snijders, Antoine M ^b   Kuipers, Ernst J ^c   Ylstra, Bauke ^a   Pinkel, Daniel ^b   Meuwissen, Stefan G M ^a   van Diest, Paul J ^a   Albertson, Donna G ^b   Meijer, Gerrit A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

20q13.2; Chromosomal aberrations; Comparative genomic hybridization; Gastric adenocarcinoma; Gene amplification; Microarray

Indexed keywords

CONTIG; DNA; GENOMIC DNA;

ADULT; AGED; AMPLICON; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CHROMOSOME 20Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE TARGETING; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; ONCOGENE; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 20; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 0037672295     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1359     Document Type: Review

References (48)

1. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-1131.
2. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791.
3. Sipponen P, Hyvarinen H, Seppala K, Blaser MJ. Review article: Pathogenesis of the transformation from gastritis to malignancy. Aliment Pharmacol Ther 1998; 12(Suppl 1): 61-71.
4. Zur HA, van Grieken NC, Meijer GA, et al. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 2001; 121: 612-618.
5. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.
6. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999; 9: M57-M60.
7. Larramendy ML, El Rifai W, Kokkola A, et al. Comparative genomic hybridization reveals differences in DNA copy number changes between sporadic gastric carcinomas and gastric carcinomas from patients with hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 1998; 106: 62-65.
8. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
9. Guan X, Fu S, Xia J, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000; 123: 27-34.
10. Kokkola A, Monni O, Puolakkainen P, et al. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 1997; 20: 38-43.
11. Koo SH, Kwon KC, Shin SY, et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 2000; 117: 97-103.
12. Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998; 23: 307-316.
13. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24: 299-305.
14. van Grieken NC, Weiss MM, Meijer GA, et al. Helicobacter pylori-related and -non-related gastric cancers do not differ with respect to chromosomal aberrations. J Pathol 2000; 192: 301-306.
15. Varis A, Puolakkainen P, Savolainen H, et al. DNA copy number profiling in esophageal Barrett adenocarcinoma: comparison with gastric adenocarcinoma and esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2001; 127: 53-58.
16. Wu MS, Chang MC, Huang SP, et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 2001; 30: 80-86.
17. Kokkola A, Monni O, Puolakkainen P, et al. Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. Cancer Genet Cytogenet 1998; 107: 32-36.
18. El Rifai W, Harper JC, Cummings OW, et al. Consistent genetic alterations in xenografts of proximal stomach and gastroesophageal junction adenocarcinomas. Cancer Res 1998; 58: 34-37.
19. Nakanishi M, Sakakura C, Fujita Y, et al. Genomic alterations in primary gastric cancers analyzed by comparative genomic hybridization and clinicopathological factors. Hepatogastroenterology 2000; 47: 658-662.
20. Oga A, Kong G, Ishii Y, Izumi H, Park CY, Sasaki K. Preferential loss of 5q14-21 in intestinal-type gastric cancer with DNA aneuploidy. Cytometry 2001; 46: 57-62.
21. van Dekken H, Alers JC, Riegman PHJ, Rosenberg C, Tilanus HW, Vissers K. Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol 2001; 158: 1961-1967.
22. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet 2000; 25: 144-146.
23. Fukushige S, Waldman FM, Kimura M, et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997; 19: 161-169.
24. Korn WM, Yasutake T, Kuo WL, et al. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 1999; 25: 82-90.
25. Meijer GA, Hermsen MAJA, Baak JPA, et al. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998; 51: 901-909.
26. Sonoda G, Palazzo J, du Manoir S, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997; 20: 320-328.
27. Werner M, Mattis A, Aubele M, et al. 20q13.2 amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast. Virchows Arch 1999; 435: 469-472.
28. Deloukas P, Matthews L, Ashurst J. The DNA sequence and comparative analysis of human chromosome 20. Nature 2001; 414: 865-871.
29. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet 1998; 20: 207-211.
30. Snijders AM, Meijer GA, Brakenhoff RH, van den Brule AJ, van Diest PJ. Microarray techniques in pathology: tool or toy? Mol Pathol 2000; 53: 289-294.
31. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
32. Weiss MM, Hermsen MA, Meijer GA, et al. Comparative genomic hybridisation. Mol Pathol 1999; 52: 243-251.
33. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genet 2001; 29: 263-264.
34. Bastian BC, Wesselmann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999; 113: 1065-1069.
35. Hidaka S, Yasutake T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-2717.
36. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000; 6: 1833-1839.
37. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-1123.
38. Collins C, Rommens JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A 1998; 95: 8703-8708.
39. Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA. Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 1999; 26: 304-311.
40. Savelieva E, Belair CD, Newton MA, et al. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997; 14: 551-560.
41. Sakakura C, Hagiwara A, Yasuoka R, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001; 84: 824-831.
42. Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 2000; 89: 217-223.
43. Collins C, Volik S, Kowbel D, et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001; 11: 1034-1042.
44. Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001; 61: 1250-1254.
45. Rosenberg C, Geelen E, Ijszenga MJ, et al. Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet Cytogenet 2002; 135: 35-41.
46. Eisman JA, Barkla DH, Tutton PJ. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987; 47: 21-25.
47. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13: 719-764.
48. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985; 1: 307-309.